Citalopram updated on 07-01-2025

ADHD (Attention deficit hyperactivity disorder): Diagnosis/Risk

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18376
R77487
Heuvelman, 2023 Attention deficit hyperactivity disorder -Medical codes or therapy records that indicated that the child had been prescribed ADHD medication - Mean age at end of follow-up 10.04 years, range 4–22 years during pregnancy (anytime or not specified) retrospective cohort (claims database) unexposed, sick Adjustment: Yes Monotherapy: no or not specified Unexposed sick: intermediate history of illness/treatment (3-12 months before pregnancy) 0.93 [0.61;1.40] -/4,620   -/16,330 - 4,620
ref
S14998
R61415
Olstad - (Es)citalopram (Controls unexposed, disease free), 2023 Attention deficit hyperactivity disorder (ADHD) diagnosis - ICD-10: F90 - Until 5 years old during pregnancy (anytime or not specified) population based cohort propective unexposed, disease free excluded Adjustment: No Matched Monotherapy: no or not specified 2.71 [1.27;5.80] C
excluded (control group)
23/306   10/344 33 306
ref
S14999
R61416
Olstad - (Es)citalopram (Controls unexposed, sick), 2023 Attention deficit hyperactivity disorder (ADHD) diagnosis - ICD-10: F90 - Until 5 years old during pregnancy (anytime or not specified) population based cohort propective unexposed, sick Adjustment: No Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 1.31 [0.69;2.48] C 23/306   18/308 41 306
ref
S18255
R76867
Suarez (Controls unexposed, discontinuers), 2022 Attention Deficit Hyperactivity Disorder - ≥ 2 dates with ICD-9 Dx 314.xx or ≥ 2 dispensings or 1 diagnosis and 1 dispensing - At ≥ 2 years of age 2nd and/or 3rd trimester retrospective cohort (claims database) unexposed, sick Adjustment: Yes Monotherapy: no or not specified Unexposed sick: recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 1.03 [0.81;1.29] 373/13,797   183/7,605 556 13,797
ref
S18256
R76868
Suarez (Controls unexposed, general pop), 2022 Attention Deficit Hyperactivity Disorder - ≥ 2 dates with ICD-9 Dx 314.xx or ≥ 2 dispensings or 1 diagnosis and 1 dispensing - At ≥ 2 years of age 2nd and/or 3rd trimester retrospective cohort (claims database) unexposed (general population or NOS) excluded Adjustment: Yes Monotherapy: no or not specified 1.23 [1.10;1.37]
excluded (control group)
374/13,818   50,747/2,920,559 51,121 13,818
ref
Total 3 studies 1.03 [0.85;1.25] 597 18,723
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Heuvelman, 2023Heuvelman, 2023 0.93[0.61; 1.40]-4,62022%ROB confusion: seriousROB selection: lowROB classification: criticalROB missing: criticalROB mesure: moderateROB reporting: low Olstad - (Es)citalopram (Controls unexposed, sick), 2023Olstad -, 2023 1 1.31[0.69; 2.48]413069%ROB confusion: seriousROB selection: unclearROB classification: moderateROB missing: lowROB mesure: criticalROB reporting: moderate Suarez (Controls unexposed, discontinuers), 2022Suarez, 2022 2 1.03[0.81; 1.29]55613,79769%ROB confusion: seriousROB selection: lowROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Total (3 studies) I2 = 0% 1.03[0.85; 1.25]59718,7230.25.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Es)citalopram (Controls unexposed, sick; 2: Controls unexposed, discontinuers;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.03[0.85; 1.25]59718,7230%NAHeuvelman, 2023 Olstad - (Es)citalopram (Controls unexposed, sick), 2023 Suarez (Controls unexposed, discontinuers), 2022 3 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 1.03[0.85; 1.25]59718,7230%NAHeuvelman, 2023 Olstad - (Es)citalopram (Controls unexposed, sick), 2023 Suarez (Controls unexposed, discontinuers), 2022 3 Tags Adjustment   - No  - No 1.31[0.69; 2.48]41306 -NAOlstad - (Es)citalopram (Controls unexposed, sick), 2023 1   - Yes  - Yes 1.01[0.82; 1.23]55618,4170%NAHeuvelman, 2023 Suarez (Controls unexposed, discontinuers), 2022 2 Monotherapy   - no or not specified  - no or not specified 1.03[0.85; 1.25]59718,7230%NAHeuvelman, 2023 Olstad - (Es)citalopram (Controls unexposed, sick), 2023 Suarez (Controls unexposed, discontinuers), 2022 3 Unexposed sick   - intermediate history of illness/tre ...  - intermediate history of illness/treatment (3-12 months before pregnancy) 0.93[0.61; 1.41]-4,620 -NAHeuvelman, 2023 1   - recent illness/treatment (during o ...  - recent illness/treatment (during or juste before pregnancy or treatment stopped in view of pregnancy) 1.06[0.85; 1.32]59714,1030%NAOlstad - (Es)citalopram (Controls unexposed, sick), 2023 Suarez (Controls unexposed, discontinuers), 2022 2 All studiesAll studies 1.03[0.85; 1.25]59718,7230%NAHeuvelman, 2023 Olstad - (Es)citalopram (Controls unexposed, sick), 2023 Suarez (Controls unexposed, discontinuers), 2022 30.25.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 18256, 14998

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.67[0.78; 3.54]51,15414,12476%NAOlstad - (Es)citalopram (Controls unexposed, disease free), 2023 Suarez (Controls unexposed, general pop), 2022 2 unexposed, sick controlsunexposed, sick controls 1.03[0.85; 1.25]59718,7230%NAHeuvelman, 2023 Olstad - (Es)citalopram (Controls unexposed, sick), 2023 Suarez (Controls unexposed, discontinuers), 2022 30.510.01.0